ArticleJournal of the advanced practitioner in oncology2026
Building Bridges: The Impact of Medical Science Liaison and Advanced Practice Provider Collaborations.
Article in Journal of the advanced practitioner in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Collaboration between medical science liaisons (MSLs) and advanced practice providers (APPs) is essential for advancing oncology care in an increasingly complex treatment landscape. Medical science liaisons serve as scientific resources, engaging in non-promotional exchange, delivering tailored education, supporting clinical research, and gathering real-world insights. These interactions help APPs stay current with evolving standards of care, interpret clinical trial data, and address knowledge gaps, while APPs provide perspectives that inform medical strategy and research priorities. This article outlines the origins and responsibilities of the MSL role, clarifies distinctions from commercial functions, and explores key pillars of collaboration: clinical research, medical education, and insight gathering. Through practical examples, it demonstrates how effective partnerships between MSLs and APPs bridge the gap between scientific innovation and clinical application, ultimately improving patient outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.